Viewing Study NCT00158860


Ignite Creation Date: 2025-12-25 @ 2:14 AM
Ignite Modification Date: 2026-06-16 @ 7:41 PM
Study NCT ID: NCT00158860
Status: COMPLETED
Last Update Posted: 2019-02-15
First Post: 2005-09-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Herpes Genitalis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None VALTREX® View
None valaciclovir View
None genital herpes View
None HSV-2 View
None suppression View